BioLargo signs MOU with Aquatech to commercialize PFAS treatment technology
BIOLARGO INC
BIOLARGO INC BLGO | 0.00 |
- BioLargo signed a non-exclusive memorandum of understanding with Aquatech to integrate its Aqueous Electrostatic Concentrator technology into Aquatech PFAS treatment flowsheets.
- Partnership targets faster commercialization of AEC as a PFAS concentration and collection step within end-to-end treatment systems that include destruction.
- AEC is designed to remove PFAS from liquid streams for drinking water applications while avoiding a secondary concentrated liquid waste stream.
- Framework covers collaboration on PFAS treatment projects worldwide, aiming to expand market reach across industrial, municipal, government customers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioLargo Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605040500ACCESSWRNAPR_____1163370) on May 04, 2026, and is solely responsible for the information contained therein.
